Serum lipid levels are the risk factors of gallbladder stones: a population-based study in China
2020 · Lipids in Health and Disease · 116 citations
https://doi.org/10.1186/s12944-019-1184-3
X
Xiaojian Ni
Fudan University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
236
Citations
5
h-index
3
i10-index
Xiaojian Ni is an academic researcher from Fudan University. The author has contributed to research in topics: Cholangiocarcinoma and Gallbladder Cancer Studies & Gallbladder and Bile Duct Disorders & Pediatric Hepatobiliary Diseases and Treatments. The author has an h-index of 5, co-authored 30 publications.
ORCID: 0000-0002-5648-5495Papers by this author
worksLiver and bile duct organoids and tumoroids
2024 · Biomedicine & Pharmacotherapy · 7 citations
https://doi.org/10.1016/j.biopha.2024.117104
Low expression of RACK1 is associated with metastasis and worse prognosis in cholangiocarcinoma
2024 · Heliyon · 2 citations
https://doi.org/10.1016/j.heliyon.2024.e27366
FUNDC1 drives cholangiocarcinoma progression via RAC1 interaction and ferroptosis suppression
2025 · International Journal of Biological Macromolecules · 1 citations
https://doi.org/10.1016/j.ijbiomac.2025.146087
Development of a Biliary Biofluid Dynamics Measurement Platform Utilizing Particle Image Velocimetry (PIV)
2025 · 0 citations
https://doi.org/10.1109/embc58623.2025.11253740
Additional file 1 of Targeting E2F8 sensitizes gemcitabine-resistant gallbladder cancer to PARP inhibitors by disrupting RRM2-driven DNA repair
2026 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.31103020
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat